The markets are as volatile as eve
This Promising Biotech Stock Could EXPLODE in March!
The biotech space is anticipated for a big rebound this year and one tiny company looks well-positioned to stand out.
Over the past 12 months, this stock has moved from around $1 to over $9. It’s evident that Wall Street is paying attention to this biotech company’s game-changing offerings for the global wound care market.
Zack’s Small Cap Research recently hiked its price target on the stock to a whopping $18.70! Clearly, the "Smart Money" thinks this stock has potential. Best of all ,the company's preliminary financial results predict a annual revenue growth of 140% compared to 2022, and its official results are set to be released in March.
Get the Details on this Blowout Biotech Stock Here & See Why Prices Could SKYROCKET in the Coming Weeks
© 2022 TheStockDork.com. All rights reserved. This is a PAID ADVERTISEMENT provided to subscribers of TheStockDork.com. Although we have sent you this email, TheStockDork.com does NOT specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Read full disclaimer here. | 